| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 141, Issue 6 1925-1933, Copyright © 1988 by American Association of Immunologists
ARTICLES |
A Gougos and M Letarte
Division of Immunology, Hospital for Sick Children, Toronto, Ontario, Canada.
Staining of a variety of human tissue sections (lymph node, tonsil, spleen, thymus, kidney, lung, and liver) by the indirect immunoperoxidase method indicated that mAb 44G4, produced against a human pre-B leukemic cell line, was strongly reactive with vascular endothelium. All other cell types observed in these tissues were unreactive. Immunofluorescence staining of endothelial cells isolated from umbilical cord vein and grown in culture confirmed that mAb 44G4 recognized a surface membrane component of vascular endothelium. Granulocytes, monocytes, B and T lymphocytes, and T lymphocytes cultured in the presence of PHA for 72 h did not express the 44G4 Ag. mAb 44G4 reacted weakly with leukemic cells from 28 of 41 patients with non-T cell acute lymphocytic leukemia and 4 of 7 patients with acute myelocytic leukemia, whereas 8 of 10 cases of T cell acute lymphocytic leukemia were negative. Moderate reactivity with leukemic cell lines of pre-B and myelomonocytic origin was also observed. The level of 44G4 Ag on umbilical endothelial cells was three to five times that of leukemic cell lines and 25 times the average levels observed on leukemic cells isolated from patients. Immunoprecipitation of lysates prepared from surface-iodinated endothelial cells and the immunizing pre-B leukemic cell line revealed that the 44G4 Ag from both cell types was composed of two subunits of apparent m.w. 95,000 linked by disulfide bond(s). Comparison of the cellular localization and subunit structure of 44G4 to that of known Ag suggests that it represents a previously undescribed marker of endothelial cells.
This article has been cited by other articles:
|
|
 |
|
  M. E. De Paepe, C. Patel, A. Tsai, S. Gundavarapu, and Q. Mao Endoglin (CD105) Up-regulation in Pulmonary Microvasculature of Ventilated Preterm Infants Am. J. Respir. Crit. Care Med., July 15, 2008; 178(2): 180 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Shariat, J. A. Karam, J. Walz, C. G. Roehrborn, F. Montorsi, V. Margulis, F. Saad, K. M. Slawin, and P. I. Karakiewicz Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers Clin. Cancer Res., June 15, 2008; 14(12): 3785 - 3791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Svatek, J. A. Karam, C. G. Roehrborn, P. I. Karakiewicz, K. M. Slawin, and S. F. Shariat Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy Clin. Cancer Res., June 1, 2008; 14(11): 3362 - 3366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Karam, R. S. Svatek, P. I. Karakiewicz, A. Gallina, C. G. Roehrborn, K. M. Slawin, and S. F. Shariat Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer Clin. Cancer Res., March 1, 2008; 14(5): 1418 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Meng, A. Lux, A. Holloschi, J. Li, J. M. X. Hughes, T. Foerg, J. E. G. McCarthy, A. M. Heagerty, P. Kioschis, M. Hafner, et al. Identification of Tctex2beta, a Novel Dynein Light Chain Family Member That Interacts with Different Transforming Growth Factor-beta Receptors J. Biol. Chem., December 1, 2006; 281(48): 37069 - 37080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. van Laake, S. van den Driesche, S. Post, A. Feijen, M. A. Jansen, M. H. Driessens, J. J. Mager, R. J. Snijder, C. J. J. Westermann, P. A. Doevendans, et al. Endoglin Has a Crucial Role in Blood Cell-Mediated Vascular Repair Circulation, November 21, 2006; 114(21): 2288 - 2297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Pimanda, W.Y. I. Chan, I. J. Donaldson, M. Bowen, A. R. Green, and B. Gottgens Endoglin expression in the endothelium is regulated by Fli-1, Erg, and Elf-1 acting on the promoter and a -8-kb enhancer Blood, June 15, 2006; 107(12): 4737 - 4745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Meurer, L. Tihaa, B. Lahme, A. M. Gressner, and R. Weiskirchen Identification of Endoglin in Rat Hepatic Stellate Cells: NEW INSIGHTS INTO TRANSFORMING GROWTH FACTOR {beta} RECEPTOR SIGNALING J. Biol. Chem., January 28, 2005; 280(4): 3078 - 3087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sanz-Rodriguez, M. Guerrero-Esteo, L.-M. Botella, D. Banville, C. P. H. Vary, and C. Bernabeu Endoglin Regulates Cytoskeletal Organization through Binding to ZRP-1, a Member of the Lim Family of Proteins J. Biol. Chem., July 30, 2004; 279(31): 32858 - 32868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Sadlier, S. B. Connolly, N. E. Kieran, S. Roxburgh, D. P. Brazil, L. Kairaitis, Y. Wang, D. C. H. Harris, P. Doran, and H. R. Brady Sequential Extracellular Matrix-focused and Baited-global Cluster Analysis of Serial Transcriptomic Profiles Identifies Candidate Modulators of Renal Tubulointerstitial Fibrosis in Murine Adriamycin-induced Nephropathy J. Biol. Chem., July 9, 2004; 279(28): 29670 - 29680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Li, R. Issa, P. Kumar, I. N. Hampson, J. M. Lopez-Novoa, C. Bernabeu, and S. Kumar CD105 prevents apoptosis in hypoxic endothelial cells J. Cell Sci., July 1, 2003; 116(13): 2677 - 2685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. DUFF, C. LI, J. M. GARLAND, and S. KUMAR CD105 is important for angiogenesis: evidence and potential applications FASEB J, June 1, 2003; 17(9): 984 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Marchuk, S. Srinivasan, T. L. Squire, and J. S. Zawistowski Vascular morphogenesis: tales of two syndromes Hum. Mol. Genet., April 2, 2003; 12(90001): R97 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Botella, T. Sanchez-Elsner, F. Sanz-Rodriguez, S. Kojima, J. Shimada, M. Guerrero-Esteo, M. P. Cooreman, V. Ratziu, C. Langa, C. P. H. Vary, et al. Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury Blood, December 1, 2002; 100(12): 4001 - 4010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sanchez-Elsner, L. M. Botella, B. Velasco, C. Langa, and C. Bernabeu Endoglin Expression Is Regulated by Transcriptional Cooperation between the Hypoxia and Transforming Growth Factor-beta Pathways J. Biol. Chem., November 8, 2002; 277(46): 43799 - 43808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rodriguez-Pena, N. Eleno, A. Duwell, M. Arevalo, F. Perez-Barriocanal, O. Flores, N. Docherty, C. Bernabeu, M. Letarte, and J. M. Lopez-Novoa Endoglin Upregulation During Experimental Renal Interstitial Fibrosis in Mice Hypertension, November 1, 2002; 40(5): 713 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Cho, A. Bourdeau, M. Letarte, and J. C. Zuniga-Pflucker Expression and function of CD105 during the onset of hematopoiesis from Flk1+ precursors Blood, December 15, 2001; 98(13): 3635 - 3642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Takahashi, A. Haba, F. Matsuno, and B. K. Seon Antiangiogenic Therapy of Established Tumors in Human Skin/Severe Combined Immunodeficiency Mouse Chimeras by Anti-Endoglin (CD105) Monoclonal Antibodies, and Synergy between Anti-Endoglin Antibody and Cyclophosphamide Cancer Res., November 1, 2001; 61(21): 7846 - 7854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-E. Paquet, N. Pece-Barbara, S. Vera, U. Cymerman, A. Karabegovic, C. Shovlin, and M. Letarte Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function Hum. Mol. Genet., June 1, 2001; 10(13): 1347 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Takahashi, R. Kawanishi-Tabata, A. Haba, M. Tabata, Y. Haruta, H. Tsai, and B. K. Seon Association of Serum Endoglin with Metastasis in Patients with Colorectal, Breast, and Other Solid Tumors, and SuppressiveEffect of Chemotherapy on the Serum Endoglin Clin. Cancer Res., March 1, 2001; 7(3): 524 - 532. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Matsubara, A. Bourdeau, K. G. terBrugge, C. Wallace, and M. Letarte Analysis of Endoglin Expression in Normal Brain Tissue and in Cerebral Arteriovenous Malformations Stroke, November 1, 2000; 31(11): 2653 - 2660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fonsatti, A. P. Jekunen, K. J. A. Kairemo, S. Coral, M. Snellman, M. R. Nicotra, P. G. Natali, M. Altomonte, and M. Maio Endoglin Is a Suitable Target for Efficient Imaging of Solid Tumors: In Vivo Evidence in a Canine Mammary Carcinoma Model Clin. Cancer Res., May 1, 2000; 6(5): 2037 - 2043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lux, C. J. Gallione, and D. A. Marchuk Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms Hum. Mol. Genet., March 22, 2000; 9(5): 745 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kruse, R. Hallmann, and E. C. Butcher Specialized Patterns of Vascular Differentiation Antigens in the Pregnant Mouse Uterus and the Placenta Biol Reprod, December 1, 1999; 61(6): 1393 - 1401. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. L Shovlin and M. Letarte Rare diseases bullet 4: Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms Thorax, August 1, 1999; 54(8): 714 - 729. [Full Text]
|
|
|
|
|
|
F. Matsuno, Y. Haruta, M. Kondo, H. Tsai, M. Barcos, and B. K. Seon Induction of Lasting Complete Regression of Preformed Distinct Solid Tumors by Targeting the Tumor Vasculature Using Two New Anti-Endoglin Monoclonal Antibodies Clin. Cancer Res., February 1, 1999; 5(2): 371 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Barbara, J. L. Wrana, and M. Letarte Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-beta Superfamily J. Biol. Chem., January 8, 1999; 274(2): 584 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rius, J. D. Smith, N. Almendro, C. Langa, L. M. Botella, D. A. Marchuk, C. P.H. Vary, and C. Bernabeu Cloning of the Promoter Region of Human Endoglin, the Target Gene for Hereditary Hemorrhagic Telangiectasia Type 1 Blood, December 15, 1998; 92(12): 4677 - 4690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Letamendia, P. Lastres, L. M. Botella, U. Raab, C. Langa, B. Velasco, L. Attisano, and C. Bernabeu Role of Endoglin in Cellular Responses to Transforming Growth Factor-beta . A COMPARATIVE STUDY WITH BETAGLYCAN J. Biol. Chem., December 4, 1998; 273(49): 33011 - 33019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Garlanda and E. Dejana Heterogeneity of Endothelial Cells : Specific Markers Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1193 - 1202. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
